Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-03-02Clinical Trial Update: Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD [Phase 2]
Phase 2 clinical trial evaluating ADC4022 co-administered with Budesonide for pulmonary inflammation in moderate-to-severe COPD. The study s…
-
FDA approval · 2009-02-27FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Budesonide and Formoterol Fumarate Dihydrate (Symbicort) by AstraZeneca Pharmaceuticals LP, …
-
CLINICAL_TRIALS trial_result · 2009-02-25Clinical Trial Update: Systemic Inflammation in Chronic Obstructive Pulmonary Disease (COPD)
An update on a clinical trial investigating systemic inflammation in chronic obstructive pulmonary disease (COPD).
-
CLINICAL_TRIALS research · 2009-02-24Clinical Trial Update: Novel Biomarkers in Chronic Airway Diseases
This clinical trial update describes research on novel biomarkers in chronic airway diseases, focusing on asthma and chronic obstructive pul…
-
CLINICAL_TRIALS trial_result · 2009-02-19Clinical Trial Update: Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 clinical trial results assess the safety and efficacy of arformoterol tartrate inhalation solution in chronic obstructive pulmonary …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-02-05Clinical Trial Update: End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
This clinical trial update focuses on end-of-life fear in patients with end-stage lung disease (COPD); no study status or results are provid…
-
CLINICAL_TRIALS trial_result · 2009-01-28Clinical Trial Update: Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease
A completed clinical trial investigating endothelial dysfunction in chronic obstructive pulmonary disease (NCT00831220).
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)
This update summarizes a completed clinical trial investigating genetic mechanisms underlying chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life [NA]
A completed randomized controlled trial evaluating mind-body breathing therapy to relieve dyspnea and improve health-related quality of life…
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Transforming Psychotherapy for Chronically Ill Patients [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating psychotherapy for chronically ill patients, including those with heart failure, COPD, …
-
FDA approval · 2008-12-16FDA Approved: ALBUTEROL SULFATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan Pharmaceuticals' original application for ALBUTEROL SULFATE as a generic product. Albuterol sulfate is a bronchodilator i…
-
CLINICAL_TRIALS trial_result · 2008-12-12Clinical Trial Update: Responses Induced by Smoking in Individuals Being Susceptible and Non-Susceptible for Development of COPD
The document reports a clinical trial update examining how smoking induces responses in individuals who are susceptible versus non-susceptib…
-
CLINICAL_TRIALS trial_result · 2008-11-27Clinical Trial Update: Correlation of Airflow Limitation and Other Respiratory Characteristics With Radiologic Changes of Lung Structure
An update on a study examining how airflow limitation and other respiratory characteristics relate to radiologic changes in the lungs of COP…
-
CLINICAL_TRIALS trial_result · 2008-11-14Clinical Trial Update: The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
A clinical trial update examining whether a Positive Expiratory Pressure (PEP) device reduces dyspnea and dynamic hyperinflation during exer…
-
FDA approval · 2008-11-13FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Spiriva HandiHaler (tiotropium bromide) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2008-10-17Clinical Trial Update: Smoking Cessation in Patients With COPD (SMOCC) in General Practice [Phase 4]
This document notes the completion of the SMOCC Phase 4 clinical trial evaluating smoking cessation strategies in patients with chronic obst…
-
FDA approval · 2008-10-14FDA Approved: ATROVENT HFA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for ATROVENT HFA (ipratropium bromide) filed by Boehringer Ingelheim Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2008-09-29Clinical Trial Update: Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 randomized trial comparing placebo to antibiotics in acute exacerbations of chronic obstructive pulmonary disease has completed.
-
FDA approval · 2008-09-16FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Supplemental Application (Nephron Pharmaceuticals Corporation)
The FDA approved a supplemental application for Nephron Pharmaceuticals Corporation's Ipratropium Bromide and Albuterol Sulfate product.
-
FDA approval · 2008-09-16FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for ALBUTEROL SULFATE HFA by Teva Pharmaceuticals USA, Inc., updating the product label through a su…
-
CLINICAL_TRIALS trial_result · 2008-09-03Clinical Trial Update: Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 trial of bisoprolol in patients with heart failure and chronic obstructive pulmonary disease has been terminated.
-
FDA approval · 2008-08-27FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) submitted by GlaxoSmithKline LLC. The approval covers the chang…
-
CLINICAL_TRIALS trial_result · 2008-08-15Clinical Trial Update: Pulmonary Function Changes in 10 Pack Year Smokers With Chronic Bronchitis
Clinical trial update reporting pulmonary function changes in 10 pack-year smokers with chronic bronchitis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2008-08-14Clinical Trial Update: Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema
Clinical trial update reporting on tiotropium’s bronchodilatory effects in COPD/emphysema patients, assessed via lung CT scoring; the study …
-
CLINICAL_TRIALS trial_result · 2008-08-13Clinical Trial Update: Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 clinical trial updates the evaluation of inhaled corticosteroids in chronic obstructive pulmonary disease and indicates the study ha…